I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Diabetes care device developer Dexcom and ŌURA, maker of the Oura smart ring, have announced a strategic partnership that aim ...

"Partnering with OURA gives us the opportunity to redefine the category again, integrating data from Dexcom glucose ...

Oura has announced a new partnership that will bring an important new metric to its smart ring app. It has teamed up with ...

Coming from a software development background, his writing spans cybersecurity,… Oura Health secures $75 million from Dexcom, ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...